Global Therapeutic Cancer Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Therapeutic Cancer Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Genetic vaccines are emerging as promising methodologies to elicit immune responses against a wide variety of antigens.
Therapeutic Cancer Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Therapeutic Cancer Vaccines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Bladder Cancer and Brain Tumors are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Therapeutic Cancer Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Therapeutic Cancer Vaccines key manufacturers include Antigenics, Asterias Biotherapeutics, Avax Technologies, Bayer, GlaxoSmithKline, Mayo Clinic, Merck, Moderna and Northwest Biotherapeutics, etc. Antigenics, Asterias Biotherapeutics, Avax Technologies are top 3 players and held % sales share in total in 2022.
Therapeutic Cancer Vaccines can be divided into Whole Cell Vaccine, Antigen Vaccine, Non-specific and Cytokine Strategies and Others, etc. Whole Cell Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Therapeutic Cancer Vaccines is widely used in various fields, such as Bladder Cancer, Brain Tumors, Breast Cancer and Lung Cancer, etc. Bladder Cancer provides greatest supports to the Therapeutic Cancer Vaccines industry development. In 2022, global % sales of Therapeutic Cancer Vaccines went into Bladder Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Therapeutic Cancer Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Antigenics
Asterias Biotherapeutics
Avax Technologies
Bayer
GlaxoSmithKline
Mayo Clinic
Merck
Moderna
Northwest Biotherapeutics
VAXIMM
Segment by Type
Whole Cell Vaccine
Antigen Vaccine
Non-specific and Cytokine Strategies
Others
Bladder Cancer
Brain Tumors
Breast Cancer
Lung Cancer
Prostate Cancer
Cervical Cancer
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Therapeutic Cancer Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Therapeutic Cancer Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Therapeutic Cancer Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Therapeutic Cancer Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Therapeutic Cancer Vaccines introduction, etc. Therapeutic Cancer Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Therapeutic Cancer Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Therapeutic Cancer Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Therapeutic Cancer Vaccines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Bladder Cancer and Brain Tumors are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Therapeutic Cancer Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Therapeutic Cancer Vaccines key manufacturers include Antigenics, Asterias Biotherapeutics, Avax Technologies, Bayer, GlaxoSmithKline, Mayo Clinic, Merck, Moderna and Northwest Biotherapeutics, etc. Antigenics, Asterias Biotherapeutics, Avax Technologies are top 3 players and held % sales share in total in 2022.
Therapeutic Cancer Vaccines can be divided into Whole Cell Vaccine, Antigen Vaccine, Non-specific and Cytokine Strategies and Others, etc. Whole Cell Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Therapeutic Cancer Vaccines is widely used in various fields, such as Bladder Cancer, Brain Tumors, Breast Cancer and Lung Cancer, etc. Bladder Cancer provides greatest supports to the Therapeutic Cancer Vaccines industry development. In 2022, global % sales of Therapeutic Cancer Vaccines went into Bladder Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Therapeutic Cancer Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Antigenics
Asterias Biotherapeutics
Avax Technologies
Bayer
GlaxoSmithKline
Mayo Clinic
Merck
Moderna
Northwest Biotherapeutics
VAXIMM
Segment by Type
Whole Cell Vaccine
Antigen Vaccine
Non-specific and Cytokine Strategies
Others
Segment by Application
Bladder Cancer
Brain Tumors
Breast Cancer
Lung Cancer
Prostate Cancer
Cervical Cancer
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Therapeutic Cancer Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Therapeutic Cancer Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Therapeutic Cancer Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Therapeutic Cancer Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Therapeutic Cancer Vaccines introduction, etc. Therapeutic Cancer Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Therapeutic Cancer Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices